Syneos Health Performance
| SYNHDelisted Stock | USD 42.31 0.07 0.17% |
The entity has a beta of 0.21, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Syneos Health's returns are expected to increase less than the market. However, during the bear market, the loss of holding Syneos Health is expected to be smaller as well. Syneos Health right now has a risk of 0.0%. Please validate Syneos Health value at risk, as well as the relationship between the skewness and day median price , to decide if Syneos Health will be following its existing price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Syneos Health has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Syneos Health is not utilizing all of its potentials. The latest stock price confusion, may contribute to short-horizon losses for the traders. ...more
| Begin Period Cash Flow | 106.5 M | |
| Total Cashflows From Investing Activities | -105.6 M |
Syneos |
Syneos Health Relative Risk vs. Return Landscape
If you would invest 4,231 in Syneos Health on August 28, 2024 and sell it today you would earn a total of 0.00 from holding Syneos Health or generate 0.0% return on investment over 90 days. Syneos Health is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Syneos, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Syneos Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Syneos Health's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Syneos Health, and traders can use it to determine the average amount a Syneos Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| SYNH |
Based on monthly moving average Syneos Health is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Syneos Health by adding Syneos Health to a well-diversified portfolio.
Syneos Health Fundamentals Growth
Syneos Stock prices reflect investors' perceptions of the future prospects and financial health of Syneos Health, and Syneos Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Syneos Stock performance.
| Return On Equity | 0.0209 | |||
| Return On Asset | 0.0263 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | 0.06 % | |||
| Current Valuation | 7.23 B | |||
| Shares Outstanding | 103.72 M | |||
| Price To Earning | 18.05 X | |||
| Price To Book | 1.07 X | |||
| Price To Sales | 0.66 X | |||
| Revenue | 5.39 B | |||
| EBITDA | 699.99 M | |||
| Cash And Equivalents | 124.2 M | |||
| Cash Per Share | 1.21 X | |||
| Total Debt | 2.9 B | |||
| Debt To Equity | 0.93 % | |||
| Book Value Per Share | 33.69 X | |||
| Cash Flow From Operations | 426.98 M | |||
| Earnings Per Share | 0.70 X | |||
| Total Asset | 8.2 B | |||
| Retained Earnings | 167.69 M | |||
| Current Asset | 1.09 B | |||
| Current Liabilities | 1.07 B | |||
About Syneos Health Performance
By evaluating Syneos Health's fundamental ratios, stakeholders can gain valuable insights into Syneos Health's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Syneos Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Syneos Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. Syneos Health, Inc. was incorporated in 2010 and is headquartered in Morrisville, North Carolina. Syneos Health operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 26751 people.Things to note about Syneos Health performance evaluation
Checking the ongoing alerts about Syneos Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Syneos Health help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Syneos Health is not yet fully synchronised with the market data | |
| Syneos Health has a very high chance of going through financial distress in the upcoming years | |
| Over 95.0% of the company shares are owned by institutional investors |
- Analyzing Syneos Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Syneos Health's stock is overvalued or undervalued compared to its peers.
- Examining Syneos Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Syneos Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Syneos Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Syneos Health's stock. These opinions can provide insight into Syneos Health's potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Consideration for investing in Syneos Stock
If you are still planning to invest in Syneos Health check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Syneos Health's history and understand the potential risks before investing.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |